IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Glenmark Life Sciences IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 1513.60 Cr. The company is based in Solapur and caters to Pharmaceutical sector. Bob Capital Markets , Bofa Securities India , Dam Capital Advisors (Formerly Idfc Securities ) , Goldman Sachs (India) Securities are the merchant bankers of Glenmark Life Sciences IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th April 2021.
Glenmark Life Sciences IPO open date is 27th July 2021 and close date is 29th July 2021. IPO Allotment Date is 3rd August 2021 and Listing date is 6th August 2021.
IPO
Size:
₹ 1513.60 Cr.
Avg IPO Size (Sector Based)
: ₹
1,431.30 cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
Bob Capital
IPO by BRLM so far:
12
City:
Solapur
IPO so far:
2
Revenue (annualised):
₹
1885.98
cr. 
PE
Ratio:
25.09x
Average Sector PE Ratio: 27.10x
Glenmark Life Sciences IPO size is ₹ 1513.60 Cr. with IPO price of ₹ 720.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Bob Capital Markets Limited is the book-running lead manager of the Glenmark Life Sciences IPO. Kfin Technologies Limited is the Registrar for Glenmark Life Sciences IPO.
Glenmark Life Sciences IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Glenmark Life Sciences IPO, based in Solapur, operates in the Pharmaceutical sector with a focus on developer and manufacturer. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Glenmark Life Sciences IPO size is ₹ 1513.60 Cr. with fresh issue size of ₹ 1,514 and Offer for sale being ₹ Nil
The IPO allotment date for Glenmark Life Sciences IPO is expected to be 3rd August 2021, after the finalization of basis of allotment. Investors can check Glenmark Life Sciences IPO allotment status on the registrars website, Kfin Technologies Limited . Glenmark Life Sciences IPO refund dates are 4th August 2021.
Glenmark Life Sciences IPO is expected to be listed on 6th August 2021.
The upper price band for the Glenmark Life Sciences IPO is set at ₹ 720.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Glenmark Life Sciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Glenmark Life Sciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 29th July 2021. After submission, funds are blocked until the basis of allotment of Glenmark Life Sciences IPO is finalised.
The merchant banker for Glenmark Life Sciences IPO is Bob Capital Markets Limited , Bofa Securities India Limited , Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , Goldman Sachs (India) Securities Private Limited . Bob Capital Markets Limited , Bofa Securities India Limited , Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , Goldman Sachs (India) Securities Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Glenmark Life Sciences IPO RHP for further details.
The registrar for Glenmark Life Sciences IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Glenmark Life Sciences IPO through their official website or helpline.
Glenmark Life Sciences IPO was subscribed 44.17 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 1,513.60 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,431.30 Cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
Bob Capital
IPO by BRLM so far:
12
City:
Solapur
IPO so far:
2
Revenue (annualised):
₹ 1,885.17 cr.
PE
Ratio:
25.09x
Average Sector PE Ratio: 27.10x
Glenmark Life Sciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Glenmark Life Sciences Financial Review Page
Merchant Banker(s) of Glenmark Life Sciences IPO: Bob Capital Markets Limited , Bofa Securities India Limited , Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , Goldman Sachs (India) Securities Private Limited
Glenmark Life Sciences IPO subscription was 44.17 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Glenmark Life Sciences IPO listed at a listing price of 748.20 against the offer price of 720.00.
The current market price of Glenmark Life Sciences is 1058.30.
Why Us?
